Zetes Industries (EBR:ZTS)

QUOTE AND NEWS
Benzinga  Dec 11  Comment 
Analysts at Cowen & Company initiated coverage on Zoetis (NYSE: ZTS) with a Market Perform rating. The target price for Zoetis is set to $47. Zoetis shares have jumped 37.22% over the past 52 weeks, while the S&P 500 index has gained 14.12%...
Benzinga  Nov 19  Comment 
In a report published Wednesday, Bank of America analyst Robert M. Willoughby reiterated a Buy rating on Zoetis Inc (NYSE: ZTS), and raised the price target from $49.00 to $51.00. In the report, Bank of America noted, “ZTS' investor day...
TheStreet.com  Nov 18  Comment 
NEW YORK (TheStreet) -- Zoetis shares are down 0.5% to $44 on Tuesday after the animal health medicine and vaccine manufacturer announced its $500 million share buyback program before the opening bell today. This announcement comes one day...
Benzinga  Nov 18  Comment 
In a report published Tuesday, Citigroup analyst Liav Abraham reiterated a Buy rating and $49.00 price target on Zoetis (NYSE: ZTS). In the report, Citigroup noted, “Following today's announcement of a pending ACT/AGN deal, coupled with...
TheStreet.com  Nov 17  Comment 
NEW YORK (TheStreet) -- Zoetis  closed trading up 2.52% to $44.22 on Monday after the animal health medicines and vaccine manufacturer announced that it's purchasing a portfolio of drugs from Abbott Laboratories  for $255 million. The...
Clusterstock  Nov 17  Comment 
The Irish pharmaceutical company Actavis is buying Allergan for $219 per share in a cash and stock deal valued at $66 billion.  For months, Allergan has worked to fend off a hostile bid from the Canadian pharmaceutical company Valeant and...
Benzinga  Nov 12  Comment 
In a report published Wednesday, Citigroup analyst Liav Abraham reiterated a Buy rating on Zoetis Inc (NYSE: ZTS), and raised the price target from $44.00 to $49.00. In the report, Citigroup noted, “Following its accumulation of a 9.7% stake...
TheStreet.com  Nov 11  Comment 
NEW YORK (TheStreet) -- Shares of Zoetis were gaining 6% to $42.58 Tuesday following reports that activist investor William Ackman has taken a stake in the animal health company. Ackman has taken a roughly $2 billion stake in the company,...
TheStreet.com  Nov 3  Comment 
NEW YORK (TheStreet) -- Shares of Zoetis were gaining 1.5% to $37.65 Monday ahead of the drug manufacturer's third-quarter earnings report before the market's open on Tuesday. Analysts surveyed by Thomson Reuters expect Zoetis to report...





 


References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki